Ongoing research highlights the significant clinical potential of incretin-based therapies, especially in emerging areas such as central nervous system disorders, substance use, and post-transplant care
doi: 10.3389/fimmu.2020.01007 Received 21 February 2020 Accepted 28 April 2020 Published 28 May 2020 Volume 11 - 2020 Edited by Laxmi Yeruva, University of Arkansas for Medical Sciences, United States Reviewed by Barbara Wrblewska, Institute of Animal Reproduction and Food Research (PAN), Poland
L., Sardao, V
PKA phosphoryle le facteur de transcription MITF (microphthalmia-associated transcription factor), upregulant la tyrosinase et les enzymes mlanogniques
36,37,38,39 Classical cardiovascular risk factors, such as arterial hypertension, diabetes, smoking, and hypercholesterolemia, are associated with endothelial dysfunction